Inspire Medical Systems, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Inspire Medical Systems, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $403.00K, a 81.46% decline year-over-year.
- Inspire Medical Systems, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $109.00K, a 98.31% decline year-over-year.
- Inspire Medical Systems, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $144.00K, a 98.99% decline year-over-year.
- Inspire Medical Systems, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $2.17M, a 60.59% decline year-over-year.
- Inspire Medical Systems, Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $9.39M, a 57.10% decline from fiscal 2024.
- Inspire Medical Systems, Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $21.90M, a 15.16% decline from fiscal 2023.
- Inspire Medical Systems, Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $25.81M, a 113.63% increase from fiscal 2022.
- Inspire Medical Systems, Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $12.08M, a 5.27% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $403.00K 10-Q · filed 2026-08-03 | |
| 2026-03-31 | $109.00K 10-Q · filed 2026-08-03 | |
| 2025-12-31 | $9.39M 10-K · filed 2026-02-13 | |
| 2025-09-30 | $144.00K 10-Q · filed 2025-11-03 | |
| 2025-06-30 | $2.17M 10-Q · filed 2026-08-03 | |
| 2025-03-31 | $6.44M 10-Q · filed 2026-08-03 | |
| 2024-12-31 | $21.90M 10-K · filed 2026-02-13 | |
| 2024-09-30 | $14.23M 10-Q · filed 2025-11-03 | |
| 2024-06-30 | $5.52M 10-Q · filed 2025-11-03 | |
| 2024-03-31 | $3.62M 10-Q · filed 2025-11-03 | |
| 2023-12-31 | $25.81M 10-K · filed 2026-02-13 | |
| 2023-09-30 | $4.02M 10-Q · filed 2024-11-04 | |
| 2023-06-30 | $13.11M 10-Q · filed 2024-11-04 | |
| 2023-03-31 | $7.38M 10-Q · filed 2024-11-04 | |
| 2022-12-31 | $12.08M 10-K · filed 2025-02-10 | |
| 2022-09-30 | $1.76M 10-Q · filed 2023-11-07 | |
| 2022-06-30 | $1.55M 10-Q · filed 2023-11-07 | |
| 2022-03-31 | $3.09M 10-Q · filed 2023-11-07 | |
| 2021-12-31 | $11.48M 10-K · filed 2024-02-09 | |
| 2021-09-30 | $3.84M 10-Q · filed 2022-11-01 | |
| 2021-06-30 | $1.72M 10-Q · filed 2022-11-01 | |
| 2021-03-31 | $3.55M 10-Q · filed 2022-11-01 | |
| 2020-12-31 | $7.05M 10-K · filed 2023-02-10 | |
| 2020-09-30 | $2.31M 10-Q · filed 2021-11-02 | $4.01M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | $732.00K 10-Q · filed 2021-11-02 | $1.89M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | $787.00K 10-Q · filed 2021-11-02 | $1.76M derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | $179.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $1.14M 10-K · filed 2022-02-15 |
| 2019-09-30 | $191.00K 10-Q · filed 2020-11-02 | $1.09M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $604.00K 10-Q · filed 2020-11-02 | $942.00K derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $166.00K 10-Q · filed 2020-11-02 | $538.00K derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $126.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $558.00K 10-K · filed 2021-02-24 |
| 2018-09-30 | $46.00K 10-Q · filed 2019-11-05 | |
| 2018-06-30 | $200.00K 10-Q · filed 2019-08-06 | |
| 2018-03-31 | $186.00K 10-Q · filed 2019-05-07 | |
| 2017-12-31 | $235.00K 10-K · filed 2020-02-25 | |
| 2016-12-31 | $189.00K 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |